Ironwood Pharmaceuticals Inc Cash Flow Reinvestment Rate
Ironwood Pharmaceuticals Inc cash flow reinvestment rate. Ironwood Pharmaceuticals Inc (IRWD) has a Cash Flow Reinvestment Rate of 0.00x as of June 2026, reinvesting $0.00 (capex $0.00 ) from operating cash flow of $58.28 Million. Explore Ironwood Pharmaceuticals Inc (IRWD) cash flow to debt to assess how comfortably operating cash covers total debt obligations.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Cash Flow Reinvestment Rate of Ironwood Pharmaceuticals Inc (2019–2025)
Cash flow reinvestment rate of Ironwood Pharmaceuticals Inc from 2019 to 2025. Historical reinvestment intensity for Ironwood Pharmaceuticals Inc across 7 annual periods. Explore IRWD capex to operating cash flow ratio to see what proportion of operating cash flow is directed to capital expenditures.
Ironwood Pharmaceuticals Inc Cash Flow Reinvestment Rate by Year (2019–2025)
Ironwood Pharmaceuticals Inc cash flow reinvestment rate by year from 2019 to 2025. Year-by-year capital reinvestment analysis for Ironwood Pharmaceuticals Inc. For the full cash flow conversion analysis, see Ironwood Pharmaceuticals Inc (IRWD) cash flow conversion.
| Year | Reinvestment Rate | Total Reinvested (USD) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.00x | $34.00K | $127.04 Million | $34.00K | ▼ -90.2% |
| 2024 | 0.00x | $284.00K | $103.55 Million | $142.00K | ▼ -100.0% |
| 2023 | 5.57x | $1.02 Billion | $183.43 Million | $273.00K | ▲ +560887.6% |
| 2022 | 0.00x | $272.00K | $273.76 Million | $136.00K | ▼ -50.9% |
| 2021 | 0.00x | $530.00K | $261.89 Million | $265.00K | ▼ -90.7% |
| 2020 | 0.02x | $3.68 Million | $168.84 Million | $1.84 Million | ▼ -98.7% |
| 2019 | 1.71x | $18.33 Million | $10.72 Million | $7.19 Million | — |